86 related articles for article (PubMed ID: 1287288)
1. [Increased fibrinogen and factor VII activity levels in patients after myocardial infarction].
Mamont B; Sawicka B
Kardiol Pol; 1992 Nov; 37(11):283-6. PubMed ID: 1287288
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K; Naruszewicz M
Mater Med Pol; 1997; 29(1-4):3-7. PubMed ID: 10214462
[TBL] [Abstract][Full Text] [Related]
4. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
Assmann G; Cullen P; Heinrich J; Schulte H
Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
7. [Estimation of the correlation between hemostatic parameters and serum lipids in patients with hyperlipidemia type II after simvastatin therapy].
Broncel M; Marczyk I; Kostka B; Michalska M; Sikora J; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Jan; 22(127):21-4. PubMed ID: 17477084
[TBL] [Abstract][Full Text] [Related]
8. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
[TBL] [Abstract][Full Text] [Related]
9. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
Cai Q; Chen J; Ma H; Song J; Xu M
Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
[TBL] [Abstract][Full Text] [Related]
10. [Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
Friesewinkel O; Marbet GA; Ritz R
Schweiz Med Wochenschr; 1993 Jan; 123(3):82-4. PubMed ID: 8426952
[TBL] [Abstract][Full Text] [Related]
11. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Ekström M; Silveira A; Bennermo M; Eriksson P; Tornvall P
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):473-7. PubMed ID: 17581323
[TBL] [Abstract][Full Text] [Related]
13. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
14. [Fibrinogen and factor VII in women with dyslipidemia. The preliminary results of the Bellvitge-Costa de Ponent Study. The Bellvitge Study Group].
Val A; Espínola A; Domenech P; Argimón JM; Castells A; Pintó X; Fiol C
Med Clin (Barc); 1995 Jul; 105(5):161-3. PubMed ID: 7630226
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
[TBL] [Abstract][Full Text] [Related]
16. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
[TBL] [Abstract][Full Text] [Related]
17. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
[TBL] [Abstract][Full Text] [Related]
18. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients.
Bruckert E; Ankri A; Jung M; Turpin G; De Gennes JL
Eur J Med; 1993; 2(8):461-5. PubMed ID: 8258046
[TBL] [Abstract][Full Text] [Related]
19. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
20. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
Thromb Haemost; 1994 Jun; 71(6):707-12. PubMed ID: 7974336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
